The SAFE — Simple Agreement for Future Equity — has quietly become the default instrument for early-stage startup financing in the United States. Introduced by Y Combinator in 2013 as a replacement for the convertible note, it now sits behind a significant share of every pre-seed and seed round closed in Silicon Valley and well beyond. For founders, it represents the fastest path from a verbal handshake to money in the bank. For investors, it offers exposure to the next generation of category-defining companies in a single-page document. And yet the SAFE remains widely misunderstood — particularly the way it converts, the dilution it creates, and the wealth-planning implications for the founders and angels who hold them. This guide walks through what SAFEs are, how they work mechanically, the trade-offs on both sides of the table, a worked numerical example, and the success stories that built the instrument's reputation.
What Is a SAFE?
A SAFE is a contract — usually five pages or fewer — under which an investor pays cash today for the right to receive shares of preferred stock in a future priced financing round. Unlike a convertible note, it is not debt. There is no interest rate, no maturity date, and no obligation to repay. The investor is simply waiting in line for the next round of equity, with a contractual mechanism that determines how many shares they will receive when that round happens.
The instrument was created by Y Combinator's then-partner Carolynn Levy in late 2013 to remove the friction and the awkward edges of convertible notes. It worked. Within five years SAFEs had displaced convertibles as the standard pre-seed instrument across YC, Techstars, 500 Global, and the broader US accelerator ecosystem. Carta — the cap-table platform used by tens of thousands of private companies — now reports that SAFEs appear on a majority of pre-seed cap tables.
Two versions of the standard SAFE exist today. The original pre-money SAFE was published in 2013. In 2018 Y Combinator released a post-money SAFE, which is now the dominant form. The distinction matters: the post-money version makes the investor's ownership percentage knowable at the moment the SAFE is signed, whereas the pre-money version leaves it dependent on what other SAFEs are signed later. We return to the difference in the dilution example below.
The Key Economic Terms
A SAFE has very few moving parts. Two economic levers do most of the work.
Valuation cap. The cap is the maximum company valuation at which the SAFE will convert into preferred shares. If the next priced round happens at a valuation below the cap, the SAFE converts at that lower valuation. If it happens above the cap, the SAFE converts as if the valuation were the cap — which is the rewarding case for the investor. A $10 million cap on a SAFE that converts at a $50 million Series A means the investor effectively bought in at a $10 million valuation and receives a 5x mark on paper at conversion.
Discount rate. A discount — typically 10% to 25% — entitles the SAFE holder to convert at a price below the priced-round price per share. A 20% discount on a Series A priced at $10 per share converts the SAFE at $8 per share. SAFEs can have a cap, a discount, both, or — less commonly — neither.
When a SAFE has both a cap and a discount, the holder receives whichever conversion produces more shares. This is the "investor-favorable" mechanic that makes SAFEs simple to reason about: the holder always gets the better of the two.
Two additional terms appear regularly. The most-favored-nation (MFN) clause lets an earlier SAFE holder adopt the more favorable terms of any later SAFE signed by the company. Pro-rata rights — sometimes attached as a side letter rather than written into the SAFE itself — allow the investor to participate in future rounds to maintain their ownership percentage. Sophisticated angels and seed funds negotiate hard for both.
How Conversion Works: A Worked Example
The clearest way to understand a SAFE is to walk a dollar of investment through to a priced round. Consider a founder who raises $1 million on a post-money SAFE with a $10 million valuation cap, no discount. At signing, the math is simple: the investor's ownership at the moment the SAFE converts will be $1M / $10M = 10% of the post-money cap table, subject to dilution from any subsequent SAFEs or rounds.
Eighteen months later, the company raises a Series A: $5 million at a $40 million pre-money valuation, or $45 million post-money. The Series A price per share is set so that the new investors receive $5M / $45M = 11.1% of the company. The SAFE now needs to convert.
Because the cap ($10M) is well below the priced-round valuation ($45M), the SAFE converts at the cap. The investor's $1M buys shares as if the company were valued at $10M, which on a post-money SAFE entitles them to 10% of the fully diluted shares immediately before the Series A new money. After the Series A dilution, the SAFE holder owns roughly 10% × (1 − 11.1%) = 8.9%. Their position is worth approximately 8.9% × $45M = $4.0M — a 4x paper return in eighteen months, before any future dilution.
If the Series A had instead priced at $8 million pre-money — below the SAFE's $10M cap — the conversion would happen at the lower priced-round valuation. The SAFE holder would receive proportionally fewer shares but would still rank ahead of common in the new preferred stock class.
The same example on a pre-money SAFE would produce a different result: the investor's percentage would be calculated against the pre-money cap table, which means additional SAFEs signed afterward would dilute them on the way to the priced round. This is exactly the problem the post-money SAFE was designed to solve, and why founders should understand which version they are signing.
The Pros — For Founders
Speed. A SAFE can be signed and funded in days rather than weeks. There is no valuation negotiation, no priced-round legal documentation, no board approval, no investor rights agreement, no voting agreement. For a founder running a 12-month runway, the speed alone often justifies the choice.
Low legal cost. A standard Y Combinator SAFE template costs nothing to use and requires minimal customisation. Compare this to a priced seed round, where founder-side and investor-side legal fees commonly run $20,000 to $50,000 combined.
No debt overhang. Unlike convertible notes, SAFEs carry no interest and no maturity date. The founder is not exposed to the risk that the note matures, the next round hasn't closed, and the noteholder demands repayment of money the company doesn't have. This single difference is what made SAFEs the dominant instrument: it eliminated a category of existential risk that founders had been quietly absorbing for years.
No valuation set early. Setting a formal valuation pre-traction is hard, and a too-high seed valuation creates a flat or down Series A — which has serious consequences for morale, hiring, and future fundraising. The valuation cap defers the decision while still giving the investor upside protection.
Clean cap table. SAFEs do not create board seats, protective provisions, or shareholder voting rights at signing. The founder retains operational control until the priced round.
The Cons — For Founders
Stacked SAFE dilution. SAFEs are deceptively easy to issue. A founder who signs five SAFEs at five different caps over twelve months may find that the cumulative dilution at the next priced round is far larger than they expected. We have seen founders surrender 35% to 40% of their company at the Series A purely from compounding SAFE conversions. Modelling the conversion at each new SAFE is essential — and most founders don't.
No price discovery. Because the SAFE defers valuation, founders sometimes raise money at caps that are dramatically below — or above — what the market would have set. A cap that felt generous in the moment can look catastrophic once the priced round confirms a much higher valuation.
Accounting complexity. Under US GAAP, many SAFEs are classified as a liability rather than equity on the balance sheet, with mark-to-market adjustments flowing through earnings. This is not a problem for an early-stage startup, but it complicates the conversation when the company prepares for a Series B or beyond.
Post-money mechanics shift dilution to the founder. The post-money SAFE — the now-dominant form — explicitly insulates the investor from dilution caused by subsequent SAFEs. Every additional SAFE the founder signs dilutes the founder, not the earlier SAFE holders. Founders raising multiple SAFE tranches need to plan the full sequence in advance.
The Pros — For Investors
Speed and access. The SAFE makes it possible for an angel investor to write a $25,000 check into a hot YC company in an afternoon. The friction reduction has democratized seed investing in a meaningful way.
Upside through the cap. A well-priced cap on a company that subsequently breaks out can deliver extraordinary returns. The companies discussed in the next section illustrate the magnitude.
Preferred-stock conversion. When the SAFE converts, it converts into the same class of preferred shares as the priced-round investors — inheriting liquidation preferences and other protective terms negotiated by the lead investor. The SAFE holder gets institutional-grade protections without doing the negotiating themselves.
The Cons — For Investors
No interest, no maturity. If the company never raises a priced round and never has a liquidity event, the SAFE can sit on the cap table indefinitely with no path to a return. There is no debt-like demand for repayment.
Limited control. SAFE holders typically have no board representation, no information rights beyond what the company chooses to provide, and limited voting power until conversion. Investors who care about governance need to negotiate side letters or wait for a priced round.
Conversion risk. If the company raises a flat or down round, or restructures, the SAFE's economics can be impaired in ways that are difficult to anticipate at signing. The SAFE's simplicity is also a constraint: it does not include the protective provisions of a priced preferred round.
QSBS clock complications. For US-taxable investors, the five-year holding period for Qualified Small Business Stock under IRC Section 1202 does not begin until the SAFE actually converts into stock. A SAFE held for three years that converts and is sold one year later does not qualify for QSBS treatment — even though the investor was at risk for four years. This is a material wealth-planning consideration for angels writing meaningful checks.
Success Stories: Companies Built on SAFEs
The instrument's reputation rests on a remarkable run of breakout outcomes from companies that used SAFEs at their earliest stages. While the precise financing histories are not always public, the following companies are widely reported to have used SAFEs in their initial rounds during or after Y Combinator participation:
Coinbase went through Y Combinator in the summer of 2012 and adopted YC's standard early-stage instruments as the SAFE was being introduced. The company went public in 2021 at a reference price valuing it at approximately $65 billion at debut. Early SAFE-style holders saw multiples that would be difficult to replicate in almost any other asset class.
DoorDash, also a YC alumnus, raised early capital on simple instruments before scaling to a 2020 IPO at a roughly $39 billion initial valuation. The pattern is consistent: small early checks on simple paper, converted into preferred stock at Series A and beyond, then carried through to a public-market exit.
Instacart, GitLab, Brex, Rippling, Faire, and dozens of others followed similar paths through YC and other accelerators that standardised on SAFE financing. None of these outcomes are guaranteed — venture investing remains a power-law business in which a small number of winners pay for a long tail of zeros — but the SAFE has been the entry point for an unusually high share of the last decade's defining technology companies.
The instrument's success has also reshaped seed investing globally. Carta's UK arm, AngelList's Rolling Funds, and the European seed ecosystem have all adopted variants of the SAFE or close analogues. In the UK specifically, the Advanced Subscription Agreement (ASA) plays a similar role and is structured to remain compatible with the country's EIS and SEIS tax-relief schemes.
When a SAFE Makes Sense — And When It Doesn't
A SAFE is the right instrument when the company is early enough that priced-round economics are premature, when the round size is modest (typically under $2 million), when the founder needs to close quickly, and when investors are comfortable with the simplicity. It is particularly well-suited to pre-seed rounds, friends-and-family rounds, and bridge financings between priced rounds.
A priced equity round is the better choice when the company has meaningful traction and the lead investor is willing to set a valuation, when the round size is large enough to justify the legal cost (typically $2 million or more), or when investor governance — board seats, protective provisions, information rights — is genuinely needed. A convertible note can be preferable in jurisdictions or company structures where SAFEs are not well-recognized, or when the parties specifically want debt-like treatment.
Wealth-Planning Implications
For founders, the SAFE is a financing decision with downstream consequences that often go unconsidered. The cumulative dilution from stacked SAFEs determines how much of the company the founder will own at the Series A, which in turn determines the long-term wealth outcome. We routinely model SAFE conversion scenarios for founders considering their next tranche of seed funding — the answer is rarely "raise the maximum amount available."
For investors, the SAFE creates wealth-planning complexity that is often overlooked at the time of writing the check. The QSBS clock issue described above is one example. The classification of SAFEs as equity or debt for individual-investor tax purposes is another — and the answer varies. Estate-planning implications also arise: a SAFE position can be transferred to a trust before conversion, potentially locking in a low valuation for gift-tax purposes if structured correctly. The window for these moves is often narrow and tied to events the investor cannot control.
For early-stage employees granted equity in a company that has raised on SAFEs, the conversion mechanics directly affect the share count and the strike price at the next 409A valuation. Understanding the cap table on a fully diluted, post-conversion basis is the only way to reason accurately about the value of an ISO or NSO grant.
The Bottom Line
The SAFE is a brilliantly designed instrument for the problem it was built to solve: getting capital into early-stage companies quickly, cheaply, and without the existential risks of convertible debt. It has earned its place as the default for pre-seed financing in the United States and increasingly beyond. But its simplicity hides real complexity at conversion, and the cumulative dilution from multiple SAFEs is a recurring source of unwelcome surprises for founders. Investors face their own set of trade-offs, particularly around QSBS treatment and the lack of governance rights.
Whether you are a founder considering your first SAFE, an angel writing a check into a friend's company, or an executive accumulating SAFE-converted preferred stock as part of your equity package, the right answer is rarely "just sign the standard document." Working through the conversion mechanics, modelling the dilution, and understanding the tax and estate consequences before signing is what separates a good outcome from an avoidable one. Our team helps clients navigate exactly these decisions — see our equity compensation planning services for more on how we work.
We help founders and angel investors model conversion scenarios, plan around dilution, and structure positions for long-term tax efficiency — including QSBS and estate-planning considerations.
